CompletedNot Applicable

Hemopatch as a Tool to Prevent Biliary Fistula in Liver Surgery.

Italy220 participantsStarted 2018-11-15

Plain-language summary

The aim of the study is to investigate the use of Hemopatch to prevent biliary fistula in patients submitted to surgery for malignancy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all patients submitted to liver surgery for malignancies. * \>18 years of age. Exclusion Criteria: * biliary reconstruction * other associated visceral resections

What they're measuring

The rate of biliary fistula

Timeframe: 12 months

Trial details

NCT IDNCT03993067

SponsorUniversity of Milan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-01-15

View on ClinicalTrials.gov More Biliary Fistula trials